BTIG Research has recently reduced BioNano Genomics Inc (BNGO) stock to Neutral rating, as announced on September 10, 2024, according to Finviz. Earlier, on January 5, 2023, Scotiabank had initiated ...

Investors often prefer to invest in shares held by company insiders, as management is typically more aligned with the company’s success and shareholder interests. Currently, insiders own just 0.52% of ...

Fintel reports that on September 10, 2024, BTIG downgraded their outlook for Bionano Genomics (NasdaqCM:BNGO) from Buy to ...

BioNano Genomics (BNGO – Research Report) received a Hold rating and price target from BTIG analyst Mark Massaro today. The ...

BTIG downgrades shares of Bionano Genomics (BNGO) from Buy to Neutral following news that the company has announced its fourth workforce reduction since May 202 ...

Inc. (BNGO) have been struggling lately and have lost 5.6% over the past week. However, a hammer chart pattern was formed in its last trading session, which could mean that the stock found support ...

Bionano Genomics Inc. (NASDAQ: BNGO) has received a rating downgrade from BTIG from Buy to Neutral following the company's announcement of another significant workforce reduction. The decision to ...

Shares of Bionano Genomics, Inc. (BNGO) have been struggling lately and have lost 5.6% over the past week. However, a hammer chart pattern was formed in its last trading session, which could mean that ...